| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81434f6cce2ace1e8350ce1db9936ce5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
1996-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcba308ebc3ef1fab4a7522c8e8afadd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb7e64b27abf828ff4db4c925e187eb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ab88f8eaf02bc0a63fe1b96ce2e16b |
| publicationDate |
2004-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0774251-B1 |
| titleOfInvention |
3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans |
| abstract |
Methods and formulations are disclosed for making and purifying the 3R-3'R stereoisomer of zeaxanthin as a sole detectable isomer, in any desired quantity, for use as a drug or vitamin by humans. Zeaxanthin preparations which contain only the desired 3R-3'R stereoisomer can be produced by a strain of Flavobacterium multivorum bacterial cells (ATCC accession number 55238). These cells (and other cells transformed with their zeaxanthin-producing genes) do not create any detectable quantities of the undesired S-S or S-R isomers of zeaxanthin. The pure R-R isomer can be taken orally, either as a therapeutic drug by patients suffering from macular degeneration, or as a vitamin or nutritional supplement to reduce the risk of age-related macular degeneration. |
| priorityDate |
1995-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |